Precautions and Warnings With Flunisolide Inhalers
There are many important precautions and warnings with flunisolide inhalers to be aware of. Among these precautions are the possibility that the flunisolide inhaler may slow the growth of some children and teenagers and the risk of infections, thrush, and glaucoma or cataracts in some people who take this medicine. There are also certain people who should not use a flunisolide inhaler at all, such as those who are allergic to any components used to make the medication.
Flunisolide inhalers will not be made, dispensed, or sold in the United States after June 30, 2011. Flunisolide inhalers contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. People using the flunisolide inhaler should ask their healthcare providers about alternatives to the medication, keeping in mind that it is possible that flunisolide inhalers may become unavailable in pharmacies earlier than the final date.
You should talk with your healthcare provider prior to using the flunisolide inhaler (Aerobid®) if you have:
- Not had chickenpox or the measles (or have not been vaccinated against them)
- Eczema (or atopic dermatitis)
- Tuberculosis, herpes, or any other infections
- Glaucoma or cataracts
- Any allergies, including allergies to food, dyes, or preservatives.
Also let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant
You should also make sure to tell your healthcare provider about all other medicines you may be taking, including prescription and non-prescription medicines, vitamins, and herbal supplements.